This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Viscos, LLC Launches New Product, Play Again™, At

Stocks in this article: GNC

INDIANAPOLIS, Jan. 15, 2014 /PRNewswire/ --  Viscos, LLC announced today the launch of Play Again ™, a clinically proven formula daily supplement for joint health, discomfort and recovery, on (NYSE: GNC), the nation's largest specialty retailer of health, wellness and sports nutrition products.  This launch expands availability to consumers of all ages who are actively looking for alternative pain management solutions, joint, ligament and tendon maintenance and long term preventative products. 

Play Again is a great tasting dietary supplement that is comprised of high molecular weight hyaluronic acid (HA) as the only active ingredient.  It is packaged in a 16 oz. bottle to consume 75mg to 225 mg daily as a replenishment of hyaluronic acid (HA), a naturally occurring molecule in the body.  HA is in the synovial fluid that coats and protects all the organs, connective tissues and joints.  HA provides hydration and cushioning.  Our formulation allows the HA to be quickly absorbed for bioavailability dispersed into the extra-cellular matrix throughout the entire body.  This formula is caffeine and gluten free, and contains zero carbs or calories.

In late 2011, Play Again was launched by Viscos, LLC in the Indianapolis market.  Shortly after launch, Play Again was quickly recognized by local orthopedic surgeons, sports medicine physicians, physical therapists and athletic trainers as an effective alternative for joint and connective tissue problems seen in their patients daily.  Viscos, LLC began a double-blind randomized clinical trial in early 2013, which is still ongoing, to obtain data for efficacy and safety of Play Again.  Debbie Ecksten, President states, "The importance of having this clinical data for medical professionals and consumers should be a priority for any manufacturer now more than ever.  This trial is the best decision we have made in the short life of our company.  There are many supplements in the market that provide claims without any strong clinical evidence." 

2013 ended as great growth for Viscos, LLC and Play Again.  Viscos, LLC market survey showed over 50% of purchasers of Play Again had a recommendation from a medical professional or an endorsement from a professional athlete.  Play Again has been become a daily supplement for many pro athletes.  Combined with our physician recommendations, rapidly developing social media penetration, increased use by athletes and active people of any age, Play Again is becoming the premium supplement in this category.  Viscos, LLC is receiving inquiries worldwide and looking forward to an international distribution by Q4 of 2014.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs